Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment

BACKGROUND: Patients with cancer are at high risk for severe coronavirus disease 2019 (COVID-19) infection. Knowledge regarding the efficacy of the messenger RNA (mRNA) vaccines in actively treated cancer patients is limited as they had been excluded from the pivotal studies of these vaccines. We ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, E., S. Fischer, R. Demmer-Steingruber, Nigg, S., Güsewell, S., Albrich, W.C., Rothermundt, C., Silzle, T., Kahlert, C.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399124/
https://www.ncbi.nlm.nih.gov/pubmed/36156449
http://dx.doi.org/10.1016/j.esmoop.2022.100587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399124/
https://www.ncbi.nlm.nih.gov/pubmed/36156449
http://dx.doi.org/10.1016/j.esmoop.2022.100587

Ejemplares similares